What is the generic name of Imitrex?

A. Tetracycline is the prototype antibiotic of the tetracycline class, originally derived from Streptomyces aureofaciens. It is a separate generic entity from doxycycline with different pharmacokinetic properties and dosing intervals. It is not the active ingredient found in the brand Vibramycin.

B. Erythromycin is a macrolide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit. It is used for patients with penicillin allergies but is chemically unrelated to the tetracycline family. It is not the generic name for Vibramycin.

C. Minocycline is a semi-synthetic tetracycline derivative used often for acne or specific bacterial infections. While it shares the same mechanism of action as doxycycline, it is a distinct chemical compound. It is marketed under brand names such as Minocin or Solodyn.

D. Doxycycline hyclate is the generic name for Vibramycin, a broad-spectrum tetracycline antibiotic. It functions by reversibly binding to the 30S ribosomal subunit, thereby preventing the binding of aminoacyl-tRNA to the mRNA-ribosome complex. This action effectively inhibits bacterial protein synthesis.

A. Piperacillin with tazobactam is a parenteral antipseudomonal penicillin combination marketed under the brand Zosyn. It is used for severe systemic infections involving Pseudomonas aeruginosa. It is not the generic composition of the oral medication known as Augmentin.

B. Augmentin is the brand name for amoxicillin with clavulanate potassium. Amoxicillin is a beta-lactam antibiotic that inhibits cell wall synthesis. Clavulanate acts as a beta-lactamase inhibitor, preventing the enzymatic degradation of amoxicillin by resistant bacterial strains.

C. Metronidazole is a nitroimidazole antimicrobial used for anaerobic infections and protozoal diseases. It functions by creating reactive free radicals that disrupt bacterial DNA. It is a single-agent generic medication and is not the active component of Augmentin.

D. Sulfamethoxazole with trimethoprim is a sulfonamide combination marketed under the brand Bactrim or Septra. This drug inhibits two consecutive steps in the bacterial folic acid synthesis pathway. It represents a different pharmacological class than the penicillin-based Augmentin.